Table 2 Receptor status, subtypes and clinical pathological features
| Â | Â | Cancer subtype | Â | Â | Â |
|---|---|---|---|---|---|
Lumina A | Lumina B | HER2 enriched | TN | p-value | |
Variable | n (%) | n (%) | n (%) | n (%) | Â |
Age below 50Â years | 11(61.1) | 6(66.6) | 1(20) | 9(45) | 0.282 |
Lymph node involvement | 11 (61.1) | 7(77.7) | 4(80) | 16(80) | 0.568 |
Ki-67 high labelling | 17(80.9) | 4(44.4) | 1(50) | 17(85) | 0.128 |
Tumour size above 6Â cm | 6(33.3) | 7 (77.7) | 5(100) | 13(65) | 0.009* |